| |
|
|
|
IBC Life Sciences, Arabella Sheraton Grand Hotel, Munich, Germany
6-8 February 2006
The innovation challenge within the pharmaceutical industry throughout Europe has led to an on-going push to improve manufacturing processes. Pharmaceutical companies are striving to be leaner so that they can strip out and drive down manufacturing costs. With a focus not only on systems and technology behind manufacturing processes, but also on compliance and supply chain considerations inherent to this topic, the manufacturing area has become a serious concern for life science organisations.IBC’s Pharmaceutical Manufacturing Science & Quality event brings solutions to your manufacturing strategy so that you can reap the rewards of lower costs, faster time to market and uncompromised quality
|
|
|
|
|
|
|
|
Organized by:
|
|
IBC Life Sciences |
|
|
Invited Speakers:
|
|
* Neil Wilkinson, Director Global Compliance, AstraZeneca & EFPIA, UK
* Jacques Morenas, Assistant Director, The French Health Products Safety Agency, France
* Joyce Ramsbotham, International Quality Specialist, Solvay & Chairperson of the EFPIA Manufacturing-GMP Working Group, The Netherlands
* Zena Kaufman, Senior Director, Regulatory Compliance, Pfizer, USA
* Malcolm Holmes, Director, Global Quality Assurance, GlaxoSmithKline & Member of EFPIA Manufacturing & GMP Adhoc Committee, UK
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
06/02/2006
|
|
|
|
|
|
|
|
Registration:
|
|
Contact Charlotte Hayes at charlotte.hayes@informa.com
http://www.ibc-lifesci.com/mansci
|
|
|
E-mail:
|
|
charlotte.hayes@informa.com
|
|
|
|
|
|
|
|
|